Low bleeding and stroke rates with minor age-dependent increase confirm the safety and effectiveness of edoxaban in patients with atrial fibrillation across age groups: Two-year results from ETNA-AF
23 April 2021 (00:00 - 00:00)
Organised by:
About the speaker
Cisanello Hospital, Pisa (Italy)
6 More presentations in this session
Professor J. De Groot (Amsterdam, NL)
Doctor S. Lee (Seoul, KR)
Access the full session
The Event
EHRA 2021
23 April - 25 April 2021
You may be interested in
Congress Presentation
Congress Session
